Therapeutic efficacy of rifaximin loaded tamarind gum polysaccharide nanoparticles in TNBS induced IBD model Wistar rats

BACKGROUND: Rifaximin is a non-systemic antibiotic used in the treatment of inflammatory bowel disease (IBD). Antibiotics are demonstrating a significant role in the treatment of IBD by altering the dysbiotic colonic microbiota and decreases the immunogenic and inflammatory response in the patient p...

Descripción completa

Detalles Bibliográficos
Autores principales: Amaldoss, Maria John Newton, Najar, Imtiyaz Ahmed, Kumar, Jatinder, Sharma, Archana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575354/
https://www.ncbi.nlm.nih.gov/pubmed/34760306
http://dx.doi.org/10.5603/RPOR.a2021.0100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575354/
https://www.ncbi.nlm.nih.gov/pubmed/34760306
http://dx.doi.org/10.5603/RPOR.a2021.0100

Ejemplares similares